Skip to main content

Table 1 Treatment of distant metastatic tumors with MAGE-1-modified DC vaccines

From: CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo

Treatment

Number of Lung metastases

DC-Ad-MAGE-1

*31.38 ± 2.26

DC-Ad-LacZ

120.75 ± 2.71

DC-MFC Ag

77.25 ± 3.37

Untreated DC

124.38 ± 3.58

  1. * P < 0.05, DC-Ad-MAGE-1 versus the other control groups.
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us